Presented at the American Urological Association’s 2025 Annual Meeting, this new data builds on Avenda Health’s previous study demonstrating Unfold AI’s ability to predict extracapsular extension risk, which was named winner of the BJUI Compass Prize 2025.
CULVER CITY, Calif., May 1, 2025 /PRNewswire/ — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, announces new study results showing its cancer mapping tool, Unfold AI, predicts cancer spread more accurately than MRI.
The pilot study, titled “Prediction of Seminal Vesicle Invasion Using Artificial Intelligence Prostate Cancer Risk Mapping,” was presented at the American Urological Association’s 2025 Annual Meeting on April 27. The results show that…